In Every Issue
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Building blocks for a healthy life, with insights from a nurse educator
Public-private partnerships for a vaccine sustain a global response to help end HIV
Living with HIV there's just one direction - forward!
IAS 2019 Conference Update
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
Current and new strategies to achieve HBV and HIV cure, and synergies between the two fields.
What advice would you give to someone who just learned they’re living with HIV?